different types of glp 1 drugs GLP-1 Receptor Agonists: An Alternative for Rapid-Acting Insulin? Evolution of GLP‐1 Receptor Agonists

Explore the implications of proposed changes to GLP-1 medication coverage and their impact on Medicare and Medicaid health plans

Discover how GLP-1 and GLP-1/GIP therapies (semaglutide and tirzepatide) influence body composition

semaglutide, n=21), weight and BMI were 90.5 kg (83.4, 107.9) and 34.0 kg/m2 (31.7, 38.7), respectively, with a post-bariatric weight regain of 15.1% (10.6, 22.8) of total body weight and 4.6 kg/m2 (3.3, 6.2)

Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are highly effective for glycaemic control and weight loss in patients with type 2 diabetes (T2D)

GLP-1 receptor agonists such as semaglutide and tirzepatide support weight loss and blood sugar control by increasing satiety and improving glucose regulation